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Introduction
The basal forebrain neurodegeneration results in 
learning and memory impairment. The basal forebrain 
cholinergic neurons along with the non-cholinergic ones 
are distributed in the medial septal nucleus, diagonal 
band nuclei, nucleus basalis, and substantia innominata. 
Several cholinergic fiber projections are sent to the 
amygdala, neocortex, and hippocampus .1
Many studies have emphasized the effects of diabetes 
mellitus, stress, and inflammation on the onset and 
progression of memory impairment. Nevertheless, 
only some of these conditions have been thoroughly 
investigated.2-4 Furthermore, these studies did not 
connect these abnormalities with a primary pathogenic 
mechanism related to the cognitive impairments; instead, 
they have merely proposed various theories and focused 
on a specific pathological condition.
Cortisol in humans or corticosterone (CORT) in 
rodents is the major stress hormone with many receptors 
in the hippocampus affecting its functions. 2 An increase 
in both acute endogenous and exogenous glucocorticoids 
can lead to lack of motivation, attention deficit, and 
memory impairment. 2,3 Similarly, stress and high-dose 
corticosterone are recognized to cause spatial memory 
deficits in rodents navigating the Morris Water Maze 
task.5
There is an exceeding interest in finding the bidirectional 
associations between the immune system and the central 
nervous system (CNS). Accordingly, a high density of 
interleukin-1 (IL-1) type I receptors in the hippocampus 6 
was associated with memory consolidation impairment. 7 
Other research studies proposed the implication of IL-
1β in neurodegenerative events,8 chronic inflammation,4 
diabetes, 9 inflammatory bowel disease, 10 asthma, 11 and 
autoimmune arthritis. 12 Moreover, IL-1β may represent a 
modulatory role in the synaptic plasticity, neuroendocrine, 
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and neurobehavioral stress responses. 13,14
Furthermore, the modulatory effects of IL-1β on brain-
derived neurotrophic factor (BDNF) are important for 
memory consolidation15 but their relationship with 
other mediators remains to be further investigated. 
Also, neurotrophins like BDNF may be involved in the 
survival, recovery, and protection of healthy and damaged 
neurons. Some studies demonstrated the role of BDNF 
and pro-BDNF in synaptic plasticity, memory processing, 
and storage 16,17 through ERK2 signaling pathways in 
the dentate gyrus and perirhinal cortex. Besides, lack 
of hippocampal BDNF gene has been associated with 
impaired spatial learning and novel object recognition.18 
In total, results of former studies suggested that aging 
and inflammation can exacerbate the hippocampal 
inflammatory responses, 6 decrease BDNF levels,15 and 
may also cause long-term memory deficits.
Other studies have focused on diabetes mellitus as a 
condition that alters the peripheral and central glucose 
metabolism. Glucose hemostasis alteration in the brain 
has important impacts on AD symptoms. 19 The brain 
needs a high energy level for generating action potentials, 
producing neurotransmitters, and cell signaling. 19 Most 
importantly, glucose homeostasis can directly affect the 
memory function in humans as well. In addition to the 
direct effects of glucose on neuronal metabolisms, insulin 
and IGF-I may indirectly affect the brain metabolism; 
hence, it may activate some phosphatidylinositol 
trisphosphate kinase pathways (e.g., Ras-MAPK-ERK 
and PI3K-Akt). Additionally, gene expression, neural 
proliferation, and activity may be regulated. 20 In this 
regard, glucose signaling pathways may have a pivotal 
role in memory function.19 Besides, neurotrophins and 
glucose metabolism mediators have similar intracellular 
signaling pathways. 20
There seems to be an important relation between BDNF, 
IL-1β, glucose, and corticosterone in the CNS, in such a 
way that cholinergic dysfunction in Alzheimer’s disease 
(AD) pathophysiology is associated with their collective 
contribution. Given this significance, the scant literature 
on this topic is very surprising. Thus, one of the major goals 
in this study is understanding the probable relationship 
among the hippocampal BDNF, IL-1β, corticosterone, 
and glucose levels. Although these mediators seem to be 
key mediators at the initial and developmental stages of 
neural damage,3,4,20 their impact on neurodegeneration 
have been studied less. The inflammatory mediators are 
often released as a consequence of neural injury and 
cause inflammation; however, the fate of other mediators 
in neurodegenerative disorders is not clearly understood. 
Hence, it is hypothesized here that nucleus basalis 
magnocellularis (NBM) injuries with the participant’s 
increase or decrease of the above-mentioned mediators 
may affect other brain areas such as the hippocampus. 3,7,16,21 
Therefore, this study was designed to evaluate the levels 
of IL1-β in the serum and hippocampus, as well as to 
measure the levels of hippocampal BDNF, corticosterone, 
and glucose after NBM lesion to verify the probability of 
such a relationship and/or its ensuing effects.
Methods and Materials 
Animals
Thirty-six male Wistar rats (250–300 g) were kept under 
a 12 h light/dark cycle at 22±2°C and with no particular 
restrictions on access to water and food. The subjects 
were randomly assigned to three equal groups (12 rats 
in each group): (1) control group, in which the rats were 
kept under similar conditions to the experimental group, 
but without any special intervention; (2) sham-operated 
group in which the animals received bilateral injections 
of saline (substance solvent) in NBM; and finally, (3) 
NBM-lesioned group, including the animals receiving 
bilateral injections of ibotenic acid. The animals in 
sham and NBM-lesioned groups were anesthetized by 
intraperitoneal injections of chloral hydrate (450 mg/kg) 
(Figure 1). Subsequently, the rats were immobilized on the 
stereotaxic apparatus (Stoelting, USA), and a small hole 
was made on either side of each skull. Ibotenic acid (10 
µg/kg; 5 µg/µL for each side, Sigma) was injected at the 
NBM with coordination of anterior-posterior (AP)=1.2, 
mead line (ML)= ±3.2 mm, dorsal-ventral (DV) = 7.5 
mm from the skull surface. 22 Also, normal saline 0.9% (5 
µg/µL) was injected bilaterally in the animals in the sham 
group.
Behavioral Apparatus and Method
The passive avoidance test was performed as our 
previously published data22 on 32 male rats (control, n=11; 
sham, n=10; and NBM-lesion, n=11). The acquisition 
trial, retention trial, and electrical foot shocks were three 
phases of the test. Each rat was habituated to the apparatus 
for 300 seconds, 20 days after the lesion induction. On the 
next day (i.e., 21 days after NBM lesion), immediately after 
the darkroom stay, the rat received a single foot electric 
shock (50 Hz, 0.2 mA and 3 s). The three retention trials 
were tested on 1, 7, and 21 days after receiving the foot 
shock. Accordingly, step-through latency (STL) and total 
time spent in the dark compartment (DS) were recorded. 
Figure 1. Experimental Protocol for Different Groups and the 
Days on Which Memory Acquisition and Retention Were Tested.
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The memory function was assessed by the remembrance 
of the received shock, that is the darkroom entrance 
latency and spending more time in the light room.
Estimation of Serum IL-1β and Hippocampal IL-1β, 
BDNF, Corticosterone, and Glucose levels
In the next step, the animals were first anesthetized with 
an intraperitoneal injection of urethane (1.5 g/kg) and 
then sacrificed. They were decapitated 42 days after the 
NBM lesion induction (i.e., 21 days after the behavioral 
test). The brains were instantly discarded from the skull; 
also, the trunk blood samples were centrifuged at the 
speed of 6000 rpm for 20 minutes. The serum samples 
were collected and stored at −80 °C until the time for 
the laboratory assays. To detect IL-1β levels in the 
hippocampus and serum, the commercial enzyme linked 
immunosorbent assay (ELISA) kits were used (Koma 
Biotech Cat# K0331212, RRID: AB_2636820).
The hippocampus of each rat was immediately dissected 
on dry ice and placed in a ProblockTM-50, EDTA-free 
(Gold Bio Co., USA) phosphate-buffered solution (PBS, 
pH 7.4, 0.01 M) and complete protease inhibitor cocktail 
solution. Afterward, the hippocampus was homogenized 
and then centrifuged (cooled centrifuge at 4°C, 10 000 
g/20 min). The samples were collected and kept at ‒80°C 
for subsequent analysis. Hippocampal CORT, BDNF, and 
glucose levels were measured according to the methods 
supplied by the manufacturers’ standard protocol of 
using ELISA kits, for BDNF (Promega Cat# G7610, 
RRID: AB_2571723), Corticosterone (DRG Cat# EIA-
4164, RRID: AB_2636819), and glucose oxidase method 
(Colorimetric Enzymatic; Pars Azmun Co., Tehran, 
Iran). Moreover, for the chemical analysis of serum and 
hippocampus, six samples were randomly selected from 
each group (i.e., 18 samples for serum and 18 samples for 
hippocampus analysis).
Histology
The approximate places of ibotenic acid injection are 
illustrated in Figure 2. The injection site was trodden on 
the brain section of the rat brain atlas.23. The formalin-
fixed brains were frozen, and serial transverse 60 μm-
thick sections of the brain were cut to verify the ibotenic 
acid injection. Eventually, histological sections were 
observed at light microscopy.
Data Analysis
Total stay time in the darkroom was analyzed using the 
nonparametric Kruskal-Wallis test followed by a two-
tailed Mann–Whitney U test.
The ANOVA analysis was used for Hippocampal 
BDNF, CORT, IL-1β, and glucose data. Accordingly, post-
hoc Tukey’s test was utilized for multiple comparisons 
of groups. Moreover, Pearson’s correlation analysis and 
linear regression were applied to identify the correlation 
between variables (means ± SEM, P < 0.05 was significant).
Results
NBM Lesion Induced Memory Deficit in Rats
Our data analysis showed no significant differences 
between control and sham groups in the latency of day 
1, 7, and 21 (Figure 3A). Thus, latency and memory 
functions were not altered by the surgery. However, 
drastic memory impairments were detected in the NBM-
Figure 3. Effect of NBM Lesion in Step-Through Latency and Time 
in Dark Compartment of Passive Avoidance Test During Retention 
Test 7 ,1, and 21 Days After Electrical Foot Shock Delivery in the 
Different Treatment Groups (Control: n= 11; Sham: n=10; NBM-
lesion: n=10), **P < 0.01, ***P < 0.001.
Figure 2. Position of Injection Cannula Tips in the NBM Regions 
of the Entorhinal Cortex for All the Rats Included in the Data 
Analyses.
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lesioned group and, after foot shock, in the sham group 
(both, on days 1, 7, and 21, P < 0.01) compared to the 
control group. A lengthy latency was considered as a sign 
of memory improvement.
The result of the total time spending in DS revealed 
that the NBM-lesioned group had significant stay time 
enhancement a day after the foot shock (day 1) compared 
to the control and sham groups (P < 0.01; Figure 3). The 
analysis also indicated that the NBM lesion had interfered 
with memory retention. As illustrated in Figure 3, the 
DS values of the NBM-lesioned group on day 7 were 
significantly longer compared with other groups (control 
and sham, P < 0.01). Moreover, the recorded DS on day 21 
for the NBM-lesioned group showed significantly higher 
values compared to other ones (respectively, P < 0.001 and 
P < 0.01 for control and sham groups).
As previously mentioned, the total DS time was analyzed 
over three trials using relevant samples to evaluate the in-
group differences. Subsequently, the obtained values of 
each group were compared between pairs of days 1 and 
7, days 7 and 21, and days 1 and 21 (Figure 4), in which 
the DS time of control and the sham groups showed no 
significant differences. 
However, in a similar comparison, the NBM-lesioned 
group exhibited a significant difference (P < 0.05; Figure 
4). Nonetheless, the DS increased in all groups in later 
days.
NBM Lesion Increased Hippocampal and Serum IL-1β 
Levels in Rats
The ANOVA and post-hoc Tukey’s analysis showed no 
significant differences (P > 0.05) between control and 
sham hippocampal IL-1β levels; this indicated that surgery 
did not impact the hippocampal IL-1β levels (Figure 5). 
Also, the hippocampal IL-1β levels increased 
significantly (P < 0.05) in the NBM-lesioned group 
compared to other groups (respectively, P < 0.01 and 
P < 0.05 in control and sham). Moreover, the serum IL-
1β levels did not show significant differences in the 
control and sham groups. However, there were significant 
differences between the NBM-lesioned group and other 
ones (Figure 5).
NBM Lesion Decreased BDNF Levels in the Hippocampus 
of Rats
No significant differences were observed in BDNF 
levels of the hippocampus between sham and control 
groups (ANOVA; Tukey’s test; P > 0.05), showing that 
surgery had no consequences on the BDNF levels after 
recovery (Figure 6A). However, a significant decrease was 
observed in the BDNF levels between NBM-lesioned and 
two other groups (respectively, P < 0.01 and P < 0.05 in 
control and sham groups). This indicates decreased levels 
of hippocampal BDNF in the NBM-lesioned rats.
NBM Lesion Increased Glucose Levels in the 
Hippocampus of Rats
Hippocampal glucose levels did not significantly differ in 
sham and control groups (ANOVA, Tukey’s test, P > 0.05). 
In Figure 6B, significant differences in the hippocampal 
glucose levels are observed between lesion, control, and 
sham groups (P < 0.05), indicating the enhancement of 
glucose levels in the NBM-lesioned rats.
NBM Lesion Increased CORT Levels in the Hippocampus 
of Rats
Based on the results of this study, hippocampal CORT 
levels did not differ significantly in the control or sham 
groups (ANOVA, Tukey’s test, P > 0.05). However, the 
hippocampal CORT levels were significantly different 
Figure 5. (A) Comparison of NBM-Lesion Effects on IL1-β Protein 
Levels in the Hippocampus, (B) in the Serum (pg/mL) in the 
Different Groups (n=6, in each group); **P < 0.01, *P < 0.05.
Figure 4. Trend Line of Time in Dark Compartment of Passive 
Avoidance Test After Electrical Foot Shock Delivery (Within 
Groups). (Control: n= 11; Sham: n=10; NBM-lesion: n=10), 
*P < 0.05.
Figure 6. (A) Comparison of NBM-Lesion Effects on BDNF 
(pg/mL); (B) Glucose (mg/dL); (C) CORT (nmol/L) Levels in the 
Hippocampus. (n=6, in each group). **P < 0.01, *P < 0.05.
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in the NBM-lesioned group compared to other groups 
(respectively, P < 0.01 and P < 0.05 in control and sham 
groups; Figure 6C).
Correlation Between Hippocampal IL-1β and Serum IL-
1β Level
Our data displayed positive significant correlations 
between hippocampus IL-1β and serum IL-1β levels in all 
experimental groups (Pearson’s analysis); correspondingly, 
the observed correlations were measured in the control 
group (r=0.835, P < 0.05), sham (r=0.851, P < 0.05) and 
NBM-lesioned (r=0.889, P < 0.01) groups (Figure 7A).
Correlations Between Hippocampal IL-1β and BDNF, 
Glucose, and CORT Levels
Similarly, the findings showed significant negative 
correlations between hippocampal IL-1β and BDNF 
levels (Pearson’s analysis); the observed correlations were 
measured in the control (r=-894, P < 0.05), sham (r=-
0.870, P < 0.05) and NBM-lesioned (r=-0.847, P < 0.05) 
groups (Figure 7B).
Additionally, there were significant positive correlations 
between the hippocampal IL-1β and glucose levels in all 
groups (Figure 7C), there were measured in the control 
group (r=0.853, P < 0.05), sham (r=0.880, P < 0.05) and 
lesion (r=0.820, P < 0.05) groups. 
Eventually, the statistical analyses demonstrated that 
hippocampal IL-1β levels significantly correlated with 
CORT levels in control, sham, and NBM-lesioned groups; 
these correlations were measured in the control group 
(r=0.866, P < 0.05), sham (r=0.835, P < 0.05) and lesion 
(r=0.874, P < 0.05) groups (Figure 7D).
Discussion
Based on our findings, the STL decreased and the DS 
time increased notably in the NBM-lesioned group on 
days 1, 7, and 21 after receiving foot shock (Figures 3–4). 
The decreased STL and increased DS in this group may 
have resulted from the disruption of the basal forebrain 
projections to other brain areas, such as the hippocampus, 
causing retention impairments. Neurodegeneration 
affects these aspects of memory deficits in numerous 
neuropsychological disorders. 1 No adaptations were 
observed in the memory retention on days 1, 7, and 21 
after receiving foot shock.
These findings propose an increase of the central and 
peripheral IL-1β levels in the NBM-lesioned group; 
This suggests that neurodegeneration of basal forebrain 
projection to the hippocampus may be initiated by 
inflammatory responses. Cytokines have a wide role in 
initiation, augmentation, continuation, and elimination 
of the inflammatory and immune responses, which makes 
them key mediators for the tissue response to damage.
There is evidence of low IL-1β levels in healthy 
brains24 and high IL-1β levels subsequent to peripheral 
infections, surgery, brain injury, and social isolation.25,26 
Also, the hippocampus has been proved to be the main 
place related to learning and memory. Therefore, it is 
reasonable to consider it as a predominant location 
of many memory-related neurotransmitters or 
neuromodulators receptors, such as IL-1 receptors.13 
Similarly, the intracerebroventricular (i.c.v.) injection 
and bilateral intra-hippocampal injection of IL-1 β (10 
or 20 ng) impaired hippocampal fear conditioning in 
healthy animals.26 As a result, the NBM lesion stimulated 
hippocampal IL-1β secretion and facilitated memory 
impairment. However, pieces of evidence either show no 
impact on memory processes, or present lucrative effects 
of IL-1β on it.27
IL-1β has been identified as a key mediator in 
neuroendocrine and neurobehavioral stress responses. 
Moreover, it has been shown that IL-1β stimulates 
the secretion of corticotrophin-releasing factor in the 
hypothalamus. 28
The involvement of the hippocampus and its basal 
forebrain cholinergic innervation in stress responses is 
regulated by the hypothalamus-pituitary-adrenal (HPA) 
axis. 3 Studies demonstrated that stress, either the acute 
Figure 7. Linear Correlation Between; (A) Hippocampal IL1-β and 
Serum IL1-β Levels; (B) Hippocampal IL1-β and BDNF Levels; 
(C) Hippocampal IL1-β and Glucose Levels; (D) Hippocampal 
IL1-β and Corticosterone (CORT) Levels in Different Groups, 
(n=6, in each group). A significant positive correlation between 
hippocampal and serum IL1-β levels. A positive correlation 
between hippocampal and serum IL1-β (Control; R=0.835, 
Sham; R=0.85 and lesion; R=0.889 groups), hippocampal IL- 
1β and Glucose levels (Control; R=0.853, Sham; R=0.880 and 
lesion; R=0.820 groups) and hippocampal IL- 1β and CORT 
levels (Control; R=0.866, Sham; R=0.835 and lesion; R=0.847 
groups) was found. A negative correlation between hippocampal 
IL- 1β and BDNF levels (Control; R= 0.866-, Sham; R= 0.870- 
and lesion; R=- 0.847 groups) was found. CORT= Corticosterone, 
BDNF= Brain Derived Neurotrophic Factor, IL- 1β= Interleukin-
1β.
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or inescapable one, is accompanied by the increased 
release of acetylcholine and regulates the acetylcholine 
availability in the prefrontal cortex and hippocampus. 
Also, this report emphasized the stress regulation via the 
involvement of the cholinergic system.29,30
The glucocorticoid, that are released under acute/
chronic stress conditions affect the cognitive functions 
in the hippocampus and prefrontal cortex. 31 As such, 
the hippocampus is introduced with a particular role 
in glucocorticoid hormone signaling, together with 
help of the HPA axis contributes to cognitive function 
modulation.2
The available evidence suggests that non-physiological 
levels of glucocorticoids can harm the hippocampal 
neurons and decrease dendrite complexity.32 Other studies 
on animals have highlighted the role of neurodegeneration 
in glucocorticoid levels of the brain. As such, the targeted 
lesions of cholinergic input to the hippocampus were 
shown to result in the HPA axis impairment and reduced 
hippocampal glucocorticoid receptors. Moreover, 
circulating corticosterone values did not represent any 
relation with the decrease in glucocorticoid receptor 
mRNA. 32,33 Hence, the hippocampal innervation 
through cholinergic neurons may normally take part in 
the modulation of glucocorticoid receptors and HPA 
functions.
In brief, the data suggest that neural involvement 
through neuroendocrine and transcriptional signaling 
pathways and other mechanisms, which could lead to 
corticosterone upregulation (following the basal forebrain 
dysfunction), could consequently develop the impairment 
of neural functions and plasticity. 32,33 In some reports, it 
is indicated that high levels of CORT over a prolonged 
period of time can cause neurodegeneration in the brain; 
moreover, it may lead to severe cognition impairment 
due to the decrease of choline acetyltransferase and 
acetylcholinesterase functions in the hippocampus. 32,33 
Also, glucocorticoids can prevent the storage and 
acetylcholine activity, by strengthening the cholinesterase 
activity. 34
Subsequent studies proposed the hippocampal protein 
kinase A (PKA) signaling alteration with cholinergic input 
elimination. 35 They documented that intensification of 
PKA signaling activity was along with pro-inflammatory 
gene expression such as inducible nitric oxide synthase 
and cyclooxygenase-2 in the hippocampus.36
Normally, a high density of glucocorticosteroid receptors 
has been reported in the mammalian hippocampus 
that can associate to negative feedback regulation of the 
HPA axis by release of glucocorticosteroids. 37 Therefore, 
the hippocampal neurons, with a crucial function in 
cognition, are specifically sensitive to injury after a single-
dose injection of CORT; this leads to the impairment of 
spatial memory and synaptic plasticity. 38,39 As mentioned 
before, both the glucocorticoids and cholinergic system 
have key functions in learning and memory. 
The considerable role of stress in memory and mental 
disorders has been indicated in other studies too. 40 CORT 
is a key stress mediator that affects memory. In this 
study, the increase of CORT levels in the NBM-lesioned 
group was suggested as an effective factor for the IL-
1β increment in stressed rats. Moreover, these findings 
showed that circulating corticosterone levels correlated 
with the hippocampal IL-1β concentration in stressed 
rats.41 Therefore, the reciprocal and severe effects of 
corticosterone, BDNF, and IL-1β on the hippocampus-
dependent memory in stress and neurodegeneration 
could be proposed. The results of this study indicate that 
NBM lesion after 42 days was associated with the decrease 
of BDNF values in the hippocampus. Recently, it has been 
proposed that HPA axis hyperactivity or a considerable 
increase of glucocorticoids, following the exposure to 
chronic CORT, may have regulatory effects on BDNF and 
CREB expressions.
On one hand, chronic CORT may induce HPA axis 
hyperactivity or excessive increase of glucocorticoid 
levels that regulate the expression of BDNF and CREB, 
thus affecting the BDNF pathway functions in the 
hippocampus. 42 On the other hand, the low expression 
value of BDNF and CREB may involve in the HPA axis 
dysfunction. 43 BDNF is synthesized in inflammatory 
cells, fibroblasts, and other cell types. 44 Moreover, some 
studies have suggested a correlation between central and 
peripheral BDNF levels, hence, concluding that BDNF 
can be cross the blood-brain barrier. Nevertheless, 
other studies could not find such a correlation; also they 
revealed that neurotrophins did not cross the blood-brain 
barrier.45
In our previously published study, an increase of 
hippocampal corticosterone levels and a decrease of 
BDNF ones were shown in stressed rats. 41 However, the 
BDNF levels were not followed by the IL-1β increase 
in these animals. This contradiction may be due to the 
synergistic inhibitory effects of IL-1β and corticosterone 
on BDNF production after the neurodegeneration. 
According to a recent report, IL-1β interferes with 
the intrinsic neurotrophic support by interrupting the 
BDNF signaling cascade; this mechanism has been 
proposed to be linked to the progression of memory 
impairments in some chronic diseases, such as AD. 8 
Besides, some studies proposed the role of corticosterone 
in suppressing the BDNF expression at the mRNA and its 
production. 46 Moreover, exposure to stress or high doses 
of glucocorticoids depressed neurogenesis and decreased 
BDNF levels.47
Neurotrophins, such as BDNF, act as critical modulators 
in the neural development, survival, and functions of the 
nervous system. 48 Therefore, impairment of the BDNF 
signaling pathways under some conditions can lead 
to neural dysfunction and neurodegenerative disease 
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symptoms, such as learning and memory deficits.
Available pieces of evidence proposed that also 
metabolic alterations play an important role in the 
initiation and progression of neurodegenerative disorders, 
such as Alzheimer’s and Parkinson’s diseases; besides, 
glucose utilization decreased in certain areas of these 
patients’ brains. 49 Moreover, proper glucose metabolism 
leads to maintaining the healthy functioning of neurons 
and other cells, mitochondrial energy production, DNA 
repair, neurotrophic factor signaling, and neuronal 
plasticity. 49 Although glucose has been proposed to 
influence memory function, it has more impact on other 
cognitive functions by synthesizing acetylcholine and 
insulin and their consequent effects on the hippocampal 
performance.50
Our results showed that hippocampal glucose 
concentration increased after NBM-lesion. However, 
some studies have proposed that low doses of central 
and peripheral IL-1β administration caused low glucose 
levels in the blood and hypothalamus. They claimed that 
treatments affected the set point for glucose homeostasis 
through the regulatory neuroendocrine mechanisms of the 
CNS 51; whereas, the present study observed synchronous 
increase of glucose, CORT, and IL-1β, plus the decrease 
of BDNF concentrations in the hippocampus of NBM-
lesioned rats. The discrepancy between our findings 
and the results of other studies on glucose levels might 
be related to methodology differences. The exogenous 
administration of IL-1β, BDNF, or CORT seems to have 
resulted in low glucose levels, while neuroinflammation, 
followed by neurodegeneration, has led to an increase in 
IL-1β and CORT, plus a decrease in BDNF concentrations 
of the brain, hence, resulting in central hyperglycemia. 
All in all, these findings propose a vigorous cycle of 
neurodegeneration along with the subsequent cascade of 
events that can alter inflammatory and neuroprotective 
metabolisms, as well as the neuroendocrine stress-related 
responses. 
In this study, the present variables related to the 
hippocampal IL-1β, glucose, BDNF, corticosterone and 
serum IL-1β concentrations (Figures 4-6) after NBM 
lesions were coupled with our formerly published data 
on memory retrieval impairment recorded 21 days after 
a foot shock in the NBM-lesioned rats; this comparison 
provided strong evidence in favor of our hypothesis 
concerning a causal relationship of these parameters.
Animal studies have suggested that central and 
peripheral inflammations are important factors in the 
damage and repair of the brain.6 Also, our results showed 
higher concentrations of IL-1β in the hippocampus 
compared to the serum. Additionally, the serum and 
hippocampal IL-1β were directly and significantly 
correlated within these groups (Figure 7). In previous 
studies, systemic inflammation has been shown to affect 
the brain and its functions. However, our result revealed 
the ability of hippocampal IL-1β for cross the blood-brain 
barrier, resulting in the probable systemic effects of the 
central neuroinflammation over time, interlinking to the 
probable systemic effects of central neuroinflammation 
over time.
In conclusion, our findings demonstrated a significant 
positive correlation among hippocampal IL-1β, 
corticosterone, and glucose, as well as a major negative 
correlation between IL-1β and BDNF in NBM-lesioned 
rats (Figure 6).
According to these findings, higher levels of IL-1β in the 
hippocampus after NBM lesion is partly induced through 
an inflammatory pathway. However, the stress-related 
biological pathways and brain metabolic dysfunction 
along with decreased BDNF levels may be responsible 
for the symptoms of some neurodegenerative diseases. 
Further investigations about these biological pathways 
are required for future studies. Therefore, considering a 
complex set of problems for managing neurodegenerative 
diseases is reasonable. Alteration of these factors will 
result in a chain of events and problems over time. Thus, 
establishing a molecular basis underlying the effect of 
our findings and the beginning time of these events is 
necessary.
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